Lyra Therapeutics’ Partnership and License Agreement with LianBio

Goodwin Procter LLP advised Lyra Therapeutics, Inc. on the deal.Lyra Therapeutics, Inc. (Nasdaq: LYRA) announced its strategic partnership and exclusive license agreement with LianBio for the development…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now